Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Andreas Ekborn"'
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 6, Iss 1, Pp 85-87 (2021)
A case is presented of an extremely low birth weight (ELBW) and growth restricted preterm twin girl with a birth weight of 532 grams who underwent an airway foreign body extraction via rigid bronchoscopy. The patient was intubated in the delivery roo
Externí odkaz:
https://doaj.org/article/0979240a318740678d8018516ab336ce
Publikováno v:
Journal of Applied Physiology. 104:912-917
To simulate pressure effects and experience thoracic compression while breath-hold diving in a relatively safe environment, competitive breath-hold divers exhale to residual volume before diving in a swimming pool, thus compressing the chest even at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4f215993daf56ef904f8cf695599cd
https://doi.org/10.1152/japplphysiol.01127.2007
https://doi.org/10.1152/japplphysiol.01127.2007
Publikováno v:
Audiology and Neurotology. 12:170-178
The antineoplastic drug cisplatin is known to cause a reduction in endocochlear potential. The hypothesis to be tested was whether a single high dose of cisplatin affects the melanocytes by altering the expression of melanin. Pigmented guinea pigs re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee2c6da5aeb0c49925a0970095319dc
https://doi.org/10.1159/000099020
https://doi.org/10.1159/000099020
Autor:
Cecilia Engmér Berglin, Andreas Ekborn, Göran Laurell, Pernilla Videhult Pierre, Katarina Edsman, Tobias Bramer, Malou Hultcrantz
Publikováno v:
Acta oto-laryngologica. 135(10)
A formulation based on sodium hyaluronate (NaHYA) was the most promising candidate vehicle for intra-tympanic drug administration regarding conductive hearing loss, inflammatory reactions, and elimination.Recent advances in inner ear research support
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac03c3f671fe052acf364f81378687aa
https://pubmed.ncbi.nlm.nih.gov/26146023
https://pubmed.ncbi.nlm.nih.gov/26146023
Publikováno v:
Hearing Research. 181:109-115
Amelioration of cisplatin-induced side-effects is of great clinical importance. Local administration of a cytoprotective agent to the inner ear offers a possibility to prevent cisplatin-induced ototoxicity without risk of interference with the antitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca242753624aee5b6ccf3d0784f7510
https://doi.org/10.1016/s0378-5955(03)00181-3
https://doi.org/10.1016/s0378-5955(03)00181-3
Publikováno v:
Hearing Research. 165:53-61
D-Methionine has recently been advocated as a protectant against cisplatin toxicity. The use of systemic D-methionine as a protector was studied in 58 guinea pigs. Kinetics and distribution of [11CH(3)]D-methionine was analysed by positron emission t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7240c71924fd39d90abeadf52c9dc6d7
https://doi.org/10.1016/s0378-5955(02)00277-0
https://doi.org/10.1016/s0378-5955(02)00277-0
Autor:
Cecilia Engmér Berglin, Katarina Edsman, Andreas Ekborn, S. Allen Counter, Tomas Klason, Tobias Bramer, Göran Laurell
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 35(3)
OBJECTIVE:To investigate the distribution and elimination of a gadolinium containing high viscosity formulation of sodium hyaluronan (HYA gel) after injection to the middle ear.MATERIALS AND METHODS:The T1 contrast agent gadolinium-diethylenetriamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::632f5b7ffccee6e9d6f1e97092f1e040
https://pubmed.ncbi.nlm.nih.gov/24270726
https://pubmed.ncbi.nlm.nih.gov/24270726
Autor:
Gunnar Wagenius, Johan Hansson, Hans Ehrsson, Göran Laurell, Inger Wallin, Andreas Ekborn, Staffan Eksborg
Publikováno v:
The Laryngoscope. 114(9)
Ototoxicity is a common side effect of high-dose cisplatin treatment. Thiol-containing chemoprotectors ameliorate cisplatin ototoxicity under experimental conditions. The trial was initiated to test the efficacy of amifostine protection in high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de58216e8b5495675dca5490f50588ac
https://pubmed.ncbi.nlm.nih.gov/15475801
https://pubmed.ncbi.nlm.nih.gov/15475801
Publikováno v:
Cancer chemotherapy and pharmacology. 51(1)
Purpose. To evaluate and compare the ototoxicity and nephrotoxicity of cisplatin and cis-diammineaquachloroplatinum(II) ion (monohydrated complex of cisplatin, MHC, formed in vivo by hydrolysis of cisplatin) after their separate administration to gui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbfb3e374826c2bfcca5dce5eeda375
https://pubmed.ncbi.nlm.nih.gov/12497204
https://pubmed.ncbi.nlm.nih.gov/12497204
Publikováno v:
Hearing research. 140(1-2)
Cisplatin (8 mg/kg) was given intravenously to guinea pigs either as a 15 s bolus injection (25 animals) or as a 1 h infusion (28 animals). To determine the influence of the mode of cisplatin administration and pharmacokinetics on the ototoxic side-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cc889839fe0d3d9d95e4886b489c30
https://pubmed.ncbi.nlm.nih.gov/10675634
https://pubmed.ncbi.nlm.nih.gov/10675634